229 related articles for article (PubMed ID: 7663802)
1. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.
Wenzel SE; Trudeau JB; Kaminsky DA; Cohn J; Martin RJ; Westcott JY
Am J Respir Crit Care Med; 1995 Sep; 152(3):897-905. PubMed ID: 7663802
[TBL] [Abstract][Full Text] [Related]
2. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA
Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
Liu MC; Dubé LM; Lancaster J
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
[TBL] [Abstract][Full Text] [Related]
4. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ
Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
[TBL] [Abstract][Full Text] [Related]
5. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
[TBL] [Abstract][Full Text] [Related]
6. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
Lehnigk B; Rabe KF; Dent G; Herst RS; Carpentier PJ; Magnussen H
Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
[TBL] [Abstract][Full Text] [Related]
7. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor.
Kane GC; Tollino M; Pollice M; Kim CJ; Cohn J; Murray JJ; Dworski R; Sheller J; Fish JE; Peters SP
Prostaglandins; 1995 Jul; 50(1):1-18. PubMed ID: 8588068
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects.
Fischer AR; McFadden CA; Frantz R; Awni WM; Cohn J; Drazen JM; Israel E
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1203-7. PubMed ID: 7551371
[TBL] [Abstract][Full Text] [Related]
9. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep.
Abraham WM; Ahmed A; Cortes A; Sielczak MW; Hinz W; Bouska J; Lanni C; Bell RL
Eur J Pharmacol; 1992 Jul; 217(2-3):119-26. PubMed ID: 1330588
[TBL] [Abstract][Full Text] [Related]
10. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects.
Larsson BM; Kumlin M; Sundblad BM; Larsson K; Dahlén SE; Palmberg L
Respir Med; 2006 Feb; 100(2):226-37. PubMed ID: 15939582
[TBL] [Abstract][Full Text] [Related]
12. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1.
Wenzel SE; Trudeau JB; Westcott JY; Beam WR; Martin RJ
J Allergy Clin Immunol; 1994 Nov; 94(5):870-81. PubMed ID: 7963156
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics.
Hasday JD; Meltzer SS; Moore WC; Wisniewski P; Hebel JR; Lanni C; Dubé LM; Bleecker ER
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1229-36. PubMed ID: 10764316
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
Kane GC; Pollice M; Kim CJ; Cohn J; Dworski RT; Murray JJ; Sheller JR; Fish JE; Peters SP
J Allergy Clin Immunol; 1996 Feb; 97(2):646-54. PubMed ID: 8621850
[TBL] [Abstract][Full Text] [Related]
15. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.
Nasser SM; Bell GS; Foster S; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP
Thorax; 1994 Aug; 49(8):749-56. PubMed ID: 8091318
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
Meltzer SS; Hasday JD; Cohn J; Bleecker ER
Am J Respir Crit Care Med; 1996 Mar; 153(3):931-5. PubMed ID: 8630575
[TBL] [Abstract][Full Text] [Related]
17. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.
Israel E; Rubin P; Kemp JP; Grossman J; Pierson W; Siegel SC; Tinkelman D; Murray JJ; Busse W; Segal AT; Fish J; Kaiser HB; Ledford D; Wenzel S; Rosenthal R; Cohn J; Lanni C; Pearlman H; Karahalios P; Drazen JM
Ann Intern Med; 1993 Dec; 119(11):1059-66. PubMed ID: 8239223
[TBL] [Abstract][Full Text] [Related]
18. Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects.
Nowak D; Grimminger F; Jörres R; Oldigs M; Rabe KF; Seeger W; Magnussen H
Eur Respir J; 1993 Mar; 6(3):405-12. PubMed ID: 8386107
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE
Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
